中西医结合治疗肺心病急性加重期45例疗效观察

目的：观察中西医结合治疗肺心病急性加重期45例的临床疗效.方法：90例符合纳入标准的患者随机分为观察组和对照组各45例,两组患者均给予西医的综合对症治疗和常规护理,观察组在此基础上内服中药汤剂治疗,14d后对比两组患者的临床疗效和FIB、HCT、MAP和CO的变化.结果：观察组总有效率达93.3%,高于对照组的84.4%,但差异并无统计学意义（P〉0.05）;两组患者治疗后FIB、HCT和MAP均有所下降,而CO则明显上升,与治疗前相比差异均具有统计学意义（P〈0.05）;治疗后两组各指标组间比较,观察组的FIB、HCT和MAP均低于对照组,而CO则高于对照组,差异均具有统计学意义（P〈0.05）.结论：中西医结合治疗肺心病急性加重期疗效确切,优于单纯西药治疗.

Clinical observation on treating 45 cases of acute exacerbation of pulmonary heart disease in the integrative medicine

Objective： To observe clinical effects of the integrative medicine on 45 cases of acute exacerbation of pulmonary heart disease. Methods： 90 patients were randomly divided into the observation group and the control group, 45 cases for each. Two groups were given western medicine treatment and routine care; while the control group was added TCM medicine. With 14 days oftreatment, clinical effects and the changes of FIB, HCT, MAP and CO were compared. Results： The efficiency in the observation group （93.3%） was better than （84.4%） in the control group without statistical significance （P〉0.05）. The level of FIB, HCT, MAPwas slower than that before treatment, while the level of CO was higher than before obviously （P〈0.05）; with treatment, the levelof FIB, HCT and MAP was lower than the control, while the level of CO was higher than the control with statistical significance（P〈0.05）. Conclusion： The efficacy of the integrative medicine therapy on pulmonary heart disease was confirmed, and better thanwestern medicine treatment.